Ally Bridge Group

Portfolio Co Investors 2026 for Ally Bridge Group: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Ally Bridge Group accounts for 28 tracked companies with verified cap-table data, 28 of which disclose round sizes totalling $6.2B. The median disclosed raise is $196M, and the largest is InSightec at $800M, ahead of Imperative Care ($595M) and Alumis ($529M).

The names that recur most often on these co-invested cap tables are Ally Bridge Group (28 companies), Perceptive Advisors (6 companies), Janus Henderson Investors (6 companies), Gilmartin Capital (5 companies), Elevage Medical Technologies (5 companies), T. Rowe Price (5 companies). By latest disclosed round, the market skews Series C (7), Series D (6), Series B (5), Growth (4).

Best funded Ally Bridge Group companies

  1. InSightec — $800M (latest: Growth)
  2. Imperative Care — $595M (latest: Other Equity)
  3. Alumis — $529M (latest: Series C)
  4. AdvanCell — $440M (latest: Series D)
  5. Endeavor BioMedicines — $292M (latest: Series A)
  6. NiKang Therapeutics — $260M (latest: Series C)
  7. ProfoundBio — $250M (latest: Series B)
  8. SetPoint Medical — $220M (latest: Series D)
  9. IsoPlexis — $206M (latest: Series D)
  10. Minerva Neuroscience — $200M (latest: Growth)
  11. Cardiac Dimensions — $200M (latest: Series E)
  12. CG Oncology — $200M (latest: IPO)
  13. Galvanize Therapeutics — $200M (latest: Series C)
  14. Kestra Medical Technologies, Inc. — $196M (latest: Series C)
  15. Vida Health — $188M (latest: Series Unknown)

Ally Bridge Group — related firms and companies (56)

Ally Bridge Group profile · All research reports